|
End-of-day quote
Shanghai S.E.
28/08/2026
|
5-day change | 1st Jan Change | ||
| 14.89 CNY | +0.47% |
|
-0.53% | -1.19% |
| 08-24 | Tasly Pharmaceutical to Buy 4 Billion Yuan of Wealth Management Products | MT |
| 08-24 | Tasly Pharmaceutical's Subsidiary Secures Nod to Trial TSL2402 Tablets | MT |
| Market Cap | 22.24B 3.31B 2.85B 2.67B 2.44B 4.59B 316B 4.61B 31.69B 12.37B 160B 12.41B 12.14B 529B | P/E 2026 * |
16.2x | P/E 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 20.7B 3.08B 2.65B 2.49B 2.27B 4.27B 294B 4.29B 29.49B 11.51B 148B 11.55B 11.3B 492B | EV / Sales 2026 * |
2.42x | EV / Sales 2027 * | 1.77x |
| Free-Float |
47.15% | Yield 2026 * |
2.77% | Yield 2027 * | 3.47% |
| 1 day | +0.47% | ||
| 1 week | -0.53% | ||
| Current month | -7.63% | ||
| 1 month | -5.34% | ||
| 3 months | +7.74% | ||
| 6 months | +2.76% | ||
| Current year | -1.19% |
| 1 week | 14.59 |  | 15.04 |
| 1 month | 14.59 | | 16.22 |
| Current year | 12.9 | | 16.24 |
| 1 year | 12.9 | | 16.72 |
| 3 years | 12.24 | | 18 |
| 5 years | 9.2 | | 18 |
| 10 years | 9.2 | | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 07/05/2024 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 08/07/2018 |
Xin Yang
CIO | Chief Investment Officer | 45 | 30/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Jian Wang
BRD | Director/Board Member | 72 | 01/06/2021 |
Jin Yong Cai
CHM | Chairman | 54 | 09/08/2026 |
Ke Xin Li
BRD | Director/Board Member | 58 | 07/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.47% | -0.53% | -10.57% | +8.77% | 3.31B | |
| +0.02% | +1.36% | -12.54% | -5.59% | 13.26B | |
| +0.53% | +2.99% | -32.15% | -56.36% | 4.99B | |
| +0.27% | +1.59% | -3.46% | +0.53% | 4.66B | |
| -0.43% | -1.64% | -0.25% | -29.65% | 4.02B | |
| +0.08% | +3.06% | -17.20% | +7.02% | 3.59B | |
| -0.67% | +2.71% | -2.91% | -3.69% | 3.43B | |
| -2.19% | -2.26% | -24.23% | -12.67% | 2.38B | |
| +0.74% | +2.97% | -26.68% | -9.75% | 1.72B | |
| -0.22% | +4.17% | -0.22% | -10.71% | 1.7B | |
| Average | -0.14% | +2.40% | -13.02% | -11.21% | 4.31B | |
| Weighted average by Cap. | -0.05% | +1.93% | -12.88% | -11.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.56B 1.27B 1.1B 1.03B 939M 1.77B 122B 1.77B 12.2B 4.76B 61.39B 4.78B 4.67B 204B | 9.32B 1.39B 1.19B 1.12B 1.02B 1.92B 132B 1.93B 13.28B 5.18B 66.84B 5.2B 5.09B 222B |
| Net income | 1.37B 204M 176M 165M 151M 284M 19.51B 285M 1.96B 763M 9.85B 766M 750M 32.66B | 1.65B 246M 212M 198M 181M 341M 23.47B 342M 2.35B 919M 11.85B 922M 902M 39.29B |
| Net Debt | -1.54B -229M -198M -185M -169M -319M -21.93B -320M -2.2B -858M -11.07B -862M -843M -36.71B | -5.71B -849M -732M -686M -626M -1.18B -81.14B -1.18B -8.14B -3.18B -40.96B -3.19B -3.12B -136B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | CN¥14.89 | +0.47% | 15,263,887 |
| 27/08/26 | CN¥14.82 | +0.34% | 13,596,225 |
| 26/08/26 | CN¥14.77 | +0.14% | 13,777,567 |
| 25/08/26 | CN¥14.75 | -0.47% | 12,437,989 |
| 24/08/26 | CN¥14.82 | -1.00% | 17,084,748 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Select your edition
All financial news and data tailored to specific country editions
